Linical Co., Ltd. (JP:2183) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Linical Co., Ltd. reported a decline in net sales for the first half of 2024, with a 10.5% decrease compared to the same period in 2023, leading to a loss in profit attributable to owners of the parent. Despite the decrease in financial performance, the company maintains a stable shareholder equity ratio of 42.7%. Looking forward, Linical forecasts a further decline in profits for the full fiscal year ending March 2025.
For further insights into JP:2183 stock, check out TipRanks’ Stock Analysis page.